Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€7.05
08.02.24
-
08.03.24
-10.64%
09.03.24

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€45.45
08.02.24
-
08.03.24
8.36%
09.03.24

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€25.56
08.02.24
-
08.03.24
0.31%
09.03.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€28.86
05.02.24
-
05.03.24
-8.80%
06.03.24

buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€7.00
05.02.24
-
05.03.24
-2.86%
06.03.24

buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€185.00
04.02.24
€130.00
04.03.24
-
05.03.24

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€41.34
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€451.50
26.01.24
-
26.02.24
7.31%
27.02.24

buy
Grifols S.A.

Start price
Target price
Perf. (%)
€8.53
12.01.24
-
12.01.25
1.81%
20.01.24

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€37.07
10.01.24
€45.00
10.01.25
-3.86%
20.01.24

buy
Grifols S.A.

Start price
Target price
Perf. (%)
€9.54
09.01.24
-
09.01.25
24.03%
10.01.24

Could be worthwhile Investment >10% per year
Good culture
Few uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.05
07.01.24
-
07.02.24
-5.36%
08.02.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€35.35
05.01.24
-
0.00%
05.01.24

Could be worthwhile Investment >10% per year
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€47.60
05.01.24
-
05.01.25
0.63%
05.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Bayer AG

Start price
Target price
Perf. (%)
€35.00
04.01.24
-
04.01.25
1.21%
06.01.24

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€557.00
03.01.24
-
03.02.24
12.39%
04.02.24

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.96
02.01.24
€80.00
02.02.24
-6.29%
22.01.24

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
AstraZeneca plc

Start price
Target price
Perf. (%)
€120.00
27.12.23
-
27.12.24
-1.58%
08.02.24

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.50
25.12.23
-
25.12.24
6.04%
05.01.24

buy
Bayer AG

Start price
Target price
Perf. (%)
€32.58
20.12.23
-
20.01.24
-0.21%
21.01.24

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€28.48
20.12.23
-
20.12.24
0.14%
23.12.23

buy
Bayer AG

Start price
Target price
Perf. (%)
€31.51
18.12.23
-
18.01.24
3.71%
19.01.24

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€526.00
14.12.23
€558.00
14.12.24
0.57%
18.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€69.02
13.12.23
€75.00
04.04.24
25.47%
25.03.24